Sponsors

Expert panelists from Advarra’s gene therapy virtual symposium address some of the most popular questions submitted by the audience. Read part 2:

With increased efforts to engage and include patient and participant communities more closely in research, when does an IRB review become required?

The global pandemic has changed the way we think about research. Sponsors should consider how the “new normal” will impact sites and current studies.

Complex trial designs can eliminate less-promising investigational treatments quickly to speed development, but they remain under-utilized. Read more:

On Clinical Trials Day, now more than ever, it’s important to recognize and thank those unsung heroes at the focal point of research: research sites and institutions. Read more:

The coronavirus pandemic has brought genetic research to the forefront. To address emerging issues, Advarra presents its first virtual symposium. Read more:

We have addressed the most popular Q&A topics from our recent webinar on the research impact of COVID-19 in this blog post. Read more:

Everyone wants to be part of a strong work culture, but how does your organization get there? Check out three tips for building a stronger work culture.

The difference between “public” and “private” internet spaces has gained importance with the growing research use of internet and social media platforms as data sources. Read more:

Is your site prepared to participate in COVID-19 vaccine research? Registering an IBC ahead of time gives you an advantage. Read more:

Dr. Gelinas answers audience questions we weren’t able to address during the webinar.

If the clinical development time of a new treatment is to ever decrease, reducing the time in study activation is necessary so actual research can be done.